Adverse effects of summer amongst people with learning disabilities: Neuroleptic malignant syndrome

Journal of Intellectual Disability Research

Volumn 41, Issue 3, 1997, Pages 273-277

  Fitzgerald, B ^a   Middleton, J K ^a   Cooper, S A ^b,c  

^a Northampton Comm Hlthcare NHS T   (United Kingdom)

^b Rockingham Forest NHS Trust   (United Kingdom)

^c ST MARY S HOSPITAL   (United Kingdom)

Author keywords

Mental retardation; Neuroleptic malignant syndrome

Indexed keywords

CARBAMAZEPINE; FLUOXETINE; HALOPERIDOL; LITHIUM CARBONATE; NEUROLEPTIC AGENT; PROCYCLIDINE; THIORIDAZINE; ZUCLOPENTHIXOL;

ADOLESCENT; ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DEPRESSION; ENVIRONMENTAL TEMPERATURE; FEMALE; HUMAN; HYDRATION; INTERPERSONAL COMMUNICATION; LEARNING DISORDER; MALE; NEUROLEPTIC MALIGNANT SYNDROME; PSYCHOSIS; REHYDRATION; SUMMER;

EID: 0030823569     PISSN: 09642633     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2788.1997.tb00708.x     Document Type: Article

References (22)

1. Addonzio G., Susman V. L. & Roth S. D. (1986) Symptoms of neuroleptic malignant syndrome in 82 consecutive in-patients. American Journal of Psychiatry 143, 1587-90.
2. Addonozio G., Susman V. L. & Roth S. D. (1987) Neuroleptic malignant syndrome: review and analysis of 115 cases. Biological Psychiatry 22, 1004-1020.
3. Adityanjee (1991) The myth of elevated serum creatinine phosphokinase level and neuroleptic malignant syndrome. British Journal of Psychiatry 158, 706-7.
4. Boyd R. D. (1993) Neuroleptic malignant syndrome and mental retardation. Review and analysis of 29 cases. American Journal on Mental Retardation 28, 143-55.
5. Bristow M. F. & Kohen D. (1993) How 'malignant' is the neuroleptic malignant syndrome. British Medical Journal 307, 1223-4.
6. Bristow M. F. & Kohen D. (1996) Neuroleptic malignant syndrome. British Journal of Hospital Medicine 55, 517-20.
7. Buckley P. F. & Hutchinson M. (1995) Neuroleptic malignant syndrome. Journal of Neurology, Neurosurgery and Psychiatry 58, 271-3.
8. Caroff S. N. & Mann S. C. (1993) The neuroleptic malignant syndrome. Medical Clinics of North America 77, 185-202.
9. Deng M. Z., Chen G. Q. & Phillips M. R. (1990) Neuroleptic malignant syndrome in 12 out of 9792 Chinese in-patients exposed to neuroleptics. American Journal of Psychiatry 147, 1149-55.
10. Dursun S. M., Burke J. G. & Reveley M. A. (1995) Toxic serotonin syndrome or extra pyramidal side-effects? British Journal of Psychiatry 166, 401-2.
11. Gelenberg A. J., Bellinghausen B., Wojcik J. D., Falk W. E. & Sachs G. S. (1988) A prospective study of neuroleptic malignant syndrome in a short-term psychiatric hospital. American Journal of Psychiatry 145, 517-18.
12. Kellam A. M. P. (1990) The (frequently) neuroleptic (potentially) malignant syndrome. British Journal of Psychiatry 157, 169-73.
13. Kornhuber J. & Weller M. (1994) Neuroleptic malignant syndrome. Current Opinion in Neurology 7, 353-7.
14. Levenson J. L. (1985) Neuroleptic malignant syndrome. American Journal of Psychiatry 142, 1137-45.
15. Naganuma H. & Fugii I. (1994) Incidence and risk factors in neuroleptic malignant syndrome. Acta Psychiatrica Scandinavica 90, 424-6.
16. O'Dwyer A. M. & Sheppard N. P. (1993) The role of creatinine kinase in the diagnosis of neuroleptic malignant syndrome. Psychological Medicine 23, 323-6.
17. Rosebush P., Stewart T. & Gelenberg A. J. (1989) Twenty neuroleptic rechallenges after neuroleptic malignant syndrome in 15 patients. Journal of Clinical Psychiatry 50, 295-8.
18. Shalev A., Hermesh H. & Munitz H. (1988) The role of external heat load in triggering the neuroleptic malignant syndrome. American Journal of Psychiatry 145, 110-11.
19. Sternbach H. (1991) The serotonin syndrome. American Journal of Psychiatry 148, 705-13.
20. Van Agtmael M. A. & Van Harten P. N. (1995) Complete anticoagulation for treatment of neuroleptic malignant syndrome. American Journal of Psychiatry 152, 1103-4.
21. Ward M. R. & Corbett J. A. (1989) Neuroleptic malignant syndrome with hypomania and mental retardation. Journal of Mental Deficiency Research 33, 339-42.
22. Wells A. J., Sommi R. W. & Crismon M. L. (1988) Neuroleptic rechallenge after neuroleptic malignant syndrome, case report and literature review. Drug Intelligence and Clinical Pharmacy 22, 457-80.